NCT01332890 is a Phase 1 clinical trial of Sequence 1 in Healthy, sponsored by Yuhan Corporation.

Who is sponsoring NCT01332890?

NCT01332890 is sponsored by Yuhan Corporation.

What drugs are being tested in NCT01332890?

Interventions in NCT01332890: Sequence 1, Sequence 2, Sequence 3, Sequence 4, Sequence 5, Sequence 6.

Is NCT01332890 still recruiting?

NCT01332890 is currently completed. Last updated 8 July 2014.

Last reviewed 2014-07-08 · How we verify

NCT01332890

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized, Open-label, Multiple-dose, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

Completed Phase 1 Last updated 8 July 2014

What this trial tests

Phase 1 trial testing Sequence 1 in Healthy in 30 participants. Completed in 1 August 2011.

Timeline

1 April 2011

Primary endpoint
1 August 2011

1 August 2011

Quick facts

Lead sponsor	Yuhan Corporation
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 April 2011
Primary completion	1 August 2011
Estimated completion	1 August 2011
Sites	1 location across South Korea

Drugs / interventions tested

Sequence 1 — full drug profile →
Sequence 2 — full drug profile →
Sequence 3
Sequence 4 — full drug profile →
Sequence 5 — full drug profile →
Sequence 6 — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Yuhan Corporation — full company profile →

Who can join

Adults 20 to 50, male only, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Pharmacokinetics
Time frame: Blood sampling will be obtained on day 7 at each period.
Serum for each treatment period Experimental. AUCtau, Cmax will be estimated using non-compartmental analysis.

Sponsor's own description

To evaluate drug-drug interaction

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sequence 1

Trials testing the same drug.

NCT06584240 — A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity · Phase 1, PHASE2 · completed
NCT03726866 — A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects · Phase 1 · unknown

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Yuhan Corporation trials

Trials by the same sponsor.

NCT07470125 — Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers · Phase 1 · not yet recruiting
NCT07415551 — Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1- · Phase 2 · recruiting
NCT07265167 — Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects · Phase 1 · completed
NCT07111468 — Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis · Phase 3 · completed
NCT06920719 — Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01332890 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yuhan Corporation
Last refreshed: 8 July 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01332890.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing